Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

Breast cancer is the most common type of malignancy and leading cause of cancer death among women worldwide. Despite the current revolutionary advances in the field of cancer immunotherapy, clinical response in breast cancer is frequently below expectations, in part due to various mechanisms of canc...

Descripción completa

Detalles Bibliográficos
Autores principales: Navarro-Ocón, Alba, Blaya-Cánovas, Jose L., López-Tejada, Araceli, Blancas, Isabel, Sánchez-Martín, Rosario M., Garrido, María J., Griñán-Lisón, Carmen, Calahorra, Jesús, Cara, Francisca E., Ruiz-Cabello, Francisco, Marchal, Juan A., Aptsiauri, Natalia, Granados-Principal, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950730/
https://www.ncbi.nlm.nih.gov/pubmed/35335881
http://dx.doi.org/10.3390/pharmaceutics14030505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950730/
https://www.ncbi.nlm.nih.gov/pubmed/35335881
http://dx.doi.org/10.3390/pharmaceutics14030505

Ejemplares similares